TL1A Blockade: The Emerging Role in IBD Management
This activity is supported by an educational grant from Genentech, a member of the Roche Group.
This activity is supported by an educational grant from Genentech, a member of the Roche Group.
This activity is supported by an educational grant from Merck & Co., Inc.
This activity is supported by an independent educational grant from Regeneron Pharmaceuticals, Inc. and Sanofi.
This activity is supported by an educational grant from Genentech, a member of the Roche Group.
This program is supported by an independent educational grant from Regeneron Pharmaceuticals, Inc. and Sanofi.
This program is supported by an independent educational grant from Regeneron Pharmaceuticals, Inc. and Sanofi.
This program is supported by an independent educational grant from Regeneron Pharmaceuticals, Inc. and Sanofi.
These activities are supported by an independent educational grant from Regeneron Pharmaceuticals, Inc. and Sanofi.
This activity is supported by an educational grant from Genentech, a member of the Roche Group.
This activity is supported by an independent educational grant from Regeneron Pharmaceuticals, Inc. and Sanofi.
This activity is supported by an educational grant from Genentech, a member of the Roche Group.
This activity is supported by educational grants from AbbVie Inc.; Genentech, a member of the Roche Group; Johnson & Johnson; Merck & Co., Inc.; and Takeda Pharmaceuticals U.S.A., Inc.